Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the ...

I survived anxiety. I survived fear. I survived grief. I survived the sadness. I now wake up each day with peace, joy, confidence, and expectation. And I live every moment with urgency. I’ve got stuff ...

So when my husband, Andrew, volunteered to undergo private screening as part of our campaign coverage, my curiosity was largely about seeing a system in action. At 51, with no urinary symptoms and no ...

For patients with intraductal carcinoma of the prostate (IDC-P), prostate-specific membrane antigen positron emission tomography (PSMA PET) may not show intraprostatic uptake — even in high-grade ...

We demonstrate that patients with luminal B tumors derive clinically meaningful benefits … from the addition of apalutamide to secondary radiotherapy,” Dr Daniel Spratt said, adding that these ...

A phase 2 RCT evaluated progression of prostate-specific antigen and urinary symptoms in men with low-risk prostate cancer who were administered phytochemical-rich food and Lactobacillus probiotic ...

The United States Prostate Cancer Biomarkers Market is projected to grow from $1.48 billion in 2024 to $3.54 billion by 2033, ...

The 82-year-old was diagnosed with an aggressive form of prostate cancer in May. His daughter celebrated his successful ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

Capivasertib addition to standard therapy extended rPFS by 7.5 months in PTEN-deficient metastatic hormone-sensitive prostate ...

Nubeqa® (darolutamide) plus androgen deprivation therapy (ADT) is now available through NHS England and Wales as an option for treating adult patients with hormone-sensitive metastatic prostate cancer ...